12th June 2020

Award Nomination for Chris Hancock CTO of Creo Medical

Creo Medical Group, the medical device company focused on the emerging field of surgical endoscopy, has announced that Creo Medical founder and Chief Technology Officer, Chris Hancock, has been shortlisted for the Institution of Engineering and Technology’s (IET) A F Harvey Engineering Research Prize. 

The IET is one of the world’s largest engineering institutions with over 169,000 members in 150 countries and the prize is open to candidates globally. The A F Harvey Engineering Research Prize is awarded annually in recognition of an outstanding achievement in engineering research in the fields of medical, microwave and radar or laser/optoelectronic engineering. This year’s theme is medical engineering and technology.

The prize winner will be chosen from a shortlist of five candidates and announced in December 2020. The winning researcher will deliver a keynote lecture on their research at IET London, Savoy Place in spring 2021 and a prize fund of £350,000 will be awarded to support further research led by the recipient.

Further details of the IET and A F Harvey Engineering Research Prize can be found here: www.theiet.org/harvey

Chris Hancock, Founder and Chief Technology Officer of Creo, commented:

“I am honoured to have been put forward for the IET Harvey award and to have been shortlisted. I’m also extremely excited about the research I plan to undertake if successful, developing a very interesting method of controlling cell behaviour in a totally non-invasive manner. This technology would complement the Creo advanced energy platform and also benefit from the desire and drive to rapidly develop ideas into products that can really make a difference and help people all over the world.”

Craig Gulliford, Chief Executive Officer of Creo, commented:

“I would like to congratulate Chris on this prestigious nomination. This is a proud moment for Creo Medical and it is fantastic to see Chris recognised for his achievements and the research and development he has conducted for over 20 years. I wish him the best of luck and look forward to hearing of the result in December.”